Download

Full Text

• Hopkins, P.N., Hunt, S.C., Wu, L.L., Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel? (1999) Curr Opin Lipidol, 7, pp. 241-253
• Reaven, G., Abbasi, F., Mclaughlin, T., Obesity, insulin resistance, and cardiovascular disease (2004) Recent Prog Horm Res, 57, pp. 207-223
• Schoonjans, K., Auwerx, J., Thiazolidinediones: an update (2000) Lancet, 356, pp. 254-255
• Choi, Y., Kawazoe, Y., Murakam, K., Identification of bioactive molecules by adipogenesis profiling of organic compounds (2003) J Biol Chem, 278, pp. 7320-7324
• Kharitonenkov, A., Shiyanova, T.L., Koester, A., FGF-21 as a novel metabolic regulator (2005) J Clin Invest, 115, pp. 1627-1635
• Kramer, D., Al-Khalili, L., Perrini, S., Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor-δ (2005) Diabetes, 54, pp. 1157-1163
• Allen, T., Zhang, F., Moddie, S.A., Halofenate is a selective peroxisome proliferator-activated receptor-γ modulator with antidiabetic activity (2006) Diabetes, 55, pp. 2523-2533
• Greenspan, P., Mayer, E.P., Flower, S.D., Nile red: a selective stain for intracellular lipid droplets (1985) J Cell Biol, 100, pp. 965-973
• Chen, L., Yang, B., McNulty, J.A., GI262570, a peroxisome proliferator-activated receptor γ agonist, changes electrolytes and water reabsorption from the distal nephron in rats (2005) J Pharmacol Exp Ther, 312, pp. 718-725
• Lehmann, J.M., Moore, L.B., Smith-Oliver, T.A., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ) (1995) J Biol Chem, 270, pp. 12953-12956
• Murakami, K., Tobe, K., Ide, T., A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-α (PPAR-α) and PPARγ (1998) Diabetes, 47, pp. 1841-1847
• Sandouk, T., Reda, D., Hofmann, C., Anti-diabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells (1993) Am J Physiol Cell Physiol, 264, pp. C1600-C1608
• Hummasti, S., Tontonoz, P., The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis (2006) Mol Endocrinol, 20, pp. 1261-1275
• Cha, B.S., Ciaraldi, T.P., Carte, L., Peroxisome proliferator-activated receptor (PPAR) γ and retinoid X receptor (RXR) agonist have complimentary effects on glucose and lipid metabolism in human skeletal muscle (2001) Diabetologia, 44, pp. 444-452
• Tafuri, S.R., Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-Ll adipocytes (1996) Endocrinology, 137, pp. 4706-4712
• Vikramadithyan, K.R., Chakrabarti, R., Misra, P., Euglycemic and hypolipidemic activity of PAT5A: a unique thiazolidinedione with weak peroxisome proliferator-activated receptor γ activity (2000) Metabolism, 49, pp. 1417-1424
• Dey, D., Medicherela, S., Neogi, P., A novel peroxisome proliferator-activated γ (PPARγ) agonist, CLX-0921, has potent anti-hyperglycemic activity with low adipogenic potential (2003) Metabolism, 52, pp. 1012-1018
• Kramer, D., Shapiro, R., Adler, A., Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats (2001) Metabolism, 50, pp. 1294-1300
• Shin, H.W., Hayashi, M., Christoforidis, S., An enzymatic cascade of Rab5 effectors regulates phosphoinositide turnover in the endocytic pathway (2005) J Cell Biol, 170, pp. 607-618
• Kato, M., Suwa, A., Shimokawa, T., Glucose catabolic gene mRNA levels in skeletal muscle exhibit non-coordinate expression in hyperglycemic mice (2004) Horm Metab Res, 36, pp. 513-518
• Ranganathan, G., Unal, R., Pokrovskaya, I., The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment (2006) J of Lipid Res, 47, pp. 2444-2450
• Tanaka, T., Yamamoto, J., Iwasaki, S., Activation of peroxisome proliferator-activated receptor γ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome (2003) Proc Natl Acad Sci U S A, 100, pp. 15924-15929
• Fleury, C., Neverova, M., Collins, S., Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia (1997) Nat Genet, 15, pp. 269-272
• Boss, O., Hagen, T., Lowell, B.B., Perspectives in diabetes: uncoupling proteins 2 and 3 potential regulators of mitochondrial energy metabolism (2000) Diabetes, 49, pp. 143-156
• Chevillotte, E., Giralt, M., Miroux, B., Uncoupling protein-2 controls adiponectin gene expression in adipose tissue through the modulation of reactive oxygen species production (2007) Diabetes, 56, pp. 1042-1050
• Vettor, R., Fabris, R., Serra1, R., Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle (2002) Int J Obes, 26, pp. 838-847
• Emilsson, V., Summers, R.J., Hamilton, S., The effects of the β3-adrenocreptor agonist BRL 35135 on UCP isoform mRNA expression (1998) Biochem Biophys Res Commun, 225, pp. 450-454
• Fu, Y., Luo, N., Klein, R.L., Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation (2005) J of Lipid Res, 46, pp. 1370-1379
• Ceddia, R.B., Somwar, R., Maida, A., Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells (2005) Diabetologia, 48, pp. 132-139
• Satoh, H., Audrey Nguyen, M.T., Trujillo, M., Adenovirus-mediated adiponectin expression augments skeletal muscle insulin sensitivity in male Wistar rats (2005) Diabetes, 54, pp. 1304-1313
• Yokoyama, H., Emoto, M., Mori, K., Plasma adiponectin level is associated with insulin-stimulated non-oxidative glucose disposal (2006) J Clin Endocrinol Metab, 91, pp. 290-294
• Yamauchi, T., Kamon, J., Waki, H., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity (2001) Nat Med, 7, pp. 941-946
• Yoon, M.J., Lee, Y.G., Chung, J.J., Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor α (2006) Diabetes, 55, pp. 2562-2570
• Higuchi, K., Masaki, T., Gotoh, K., Apelin, an APJ receptor ligand, regulates body adiposity and favors the messenger ribonucleic acid expression of uncoupling proteins in mice (2007) Endocrinology, 148, pp. 2690-2697